Colorectal Cancer in Ukraine: Regional Disparities and National Trends in Incidence, Management, and Mortality
Journal of Global Oncology · 2018-12 · (4) · 1-8
DOI: 10.1200/jgo.18.00145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Global Oncology, 2018-12. Verfasst von Nelya Melnitchouk und 11 weiteren Autor:innen. Beteiligte Einrichtung: , , , , , , , and , Brigham and Women's Hospital, Harvard Medical School; , , and , Center for Surgery and Public Health, Boston; , University of Mas…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NLM NIH HHS.
Abstract (Originalsprache)
Purpose
The incidence of colorectal cancer (CRC) is increasing worldwide, and the greatest increase is in low- to middle-income countries, such as Ukraine. Better knowledge of epidemiology of CRC in Ukraine is needed to understand how best to decrease the burden of disease.
Methods
The National Cancer Registry of Ukraine (NCRU) was queried for CRC incidence, mortality, stage, and treatment in Ukraine and assessed for regional variation from 1999 to 2015. Joinpoint analysis was used to analyze the trends.
Results
The incidence of colon cancer increased from 10.6 to 13.3 occurrences per 100,000, which provided an average annual percent change (AAPC) of 1.48 (95% CI, 1.3 to 1.7; P < .05). The incidence of rectal and anal cancers also increased from 9.9 to 11.5 occurrences per 100,000, which provided an AAPC of 1.0 (95% CI, 0.8 to 1.3; P < .05). Mortality remained the same (AAPC, 0.1; 95% CI, −0.3 to 0.2; P = .4). The proportion of patients who received cancer-specific treatment increased from 54.6% to 68.5% for colon cancer and from 61% to 74.4% for rectal and anal cancers. Overall, 34.5% of patients with colon cancer and 27.5% of patients with rectal cancer died within a year of diagnosis in 2015. Great regional variations in 1-year mortality and treatment received were identified.
Conclusion
The incidence of CRC in Ukraine is increasing. Despite stable mortality rates, many do not receive cancer-specific treatment, and a large proportion of patients die within a year of diagnosis. These findings illustrate the need to promote establishment of a screening program and to improve access to cancer-specific therapy in Ukraine.
Autor:innen und Institutionen
- , , , , , , , and , Brigham and Women's Hospital, Harvard Medical School; , , and , Center for Surgery and Public Health, Boston; , University of Massachusetts Medical School, Worcester, MA; and and , National Cancer In…
Förderung
- NLM NIH HHS
Zitieren
APA
Melnitchouk, N., Shabat, G., Lu, P., Lyu, H., Scully, R., Leung, K., Jarman, M., Lukashenko, A., Kolesnik, O. O., Goldberg, J., Davids, J. S., & Bleday, R. (2018). Colorectal Cancer in Ukraine: Regional Disparities and National Trends in Incidence, Management, and Mortality. Journal of Global Oncology, 1-8. https://doi.org/10.1200/jgo.18.00145
Vancouver
Melnitchouk N, Shabat G, Lu P, Lyu H, Scully R, Leung K, et al. Colorectal Cancer in Ukraine: Regional Disparities and National Trends in Incidence, Management, and Mortality. Journal of Global Oncology. 2018:1-8. doi:10.1200/jgo.18.00145
BibTeX
@article{Melnitchouk2018,
author = {Melnitchouk, Nelya and Shabat, Galyna and Lu, Pamela and Lyu, Heather and Scully, Rebecca and Leung, Krystle and Jarman, Molly and Lukashenko, Andrey and Kolesnik, Olena O and Goldberg, Joel and Davids, Jennifer S and Bleday, Ronald},
title = {Colorectal Cancer in Ukraine: Regional Disparities and National Trends in Incidence, Management, and Mortality},
journal = {Journal of Global Oncology},
year = {2018},
number = {4},
pages = {1--8},
doi = {10.1200/jgo.18.00145}
}
EUVIMED